查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595437

聚己內酯市場：按形狀、工藝和應用分類 - 2025-2030 年全球預測

Polycaprolactone Market by Form (Granules, Pellets), Process (Polycondensation of Carboxylic Acid, Ring Opening Polymerization), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年聚己內酯市值為5.087億美元，預計2024年將達到5.3796億美元，複合年成長率為6.18%，到2030年將達到7.7446億美元。

聚己內酯（PCL）是一種生物分解性的聚酯，由於其熔點低、與各種複合材料相容性高等特性，具有廣泛的應用前景。其應用廣泛擴展到醫藥、汽車、醫療保健、包裝等領域。在製藥領域，PCL對於控制釋放系統至關重要，而在醫療保健領域，其生物分解性和生物相容性使其應用擴展到組織工程和植入。由於 PCL 的耐用性和靈活性，汽車和包裝行業主要使用 PCL。市場成長要素包括由於環境問題和有利於環保產品的監管支持而對生物分解性材料的需求不斷增加。此外，製造流程的技術進步進一步提高了機械性能和成本效率，並支持市場擴張。在醫療保健技術投資不斷增加以及專注於創新組織工程解決方案的推動下，醫療領域存在著一個顯著的機會。為了利用這些機會，公司可以投資於合作研究，重點是增強 PCL 的性能並開發具有更廣泛應用的複合材料。然而，市場面臨其他生物分解性聚合物的競爭以及與生產和材料加工相關的高成本等限制。 PCL 應對這些挑戰的能力主要取決於克服成本障礙和提高生產效率。公司可以探索積層製造技術的進步，例如允許 PCL 用於客製化醫療設備的3D 列印，以及利用 PCL控制釋放特性的藥物輸送系統的創新。市場的本質是動態的，並且有大量的研究和開發舉措致力於擴大 PCL 的應用範圍。透過優先考慮永續實踐以及與研究機構的合作，並保持在創新的前沿，公司可以最大限度地發揮先進汽車零件和環保包裝解決方案等開拓領域的潛力。

主要市場統計
基準年[2023] 5.087 億美元
預測年份 [2024] 53796萬美元
預測年份 [2030] 77446萬美元
複合年成長率（%） 6.18%

市場動態：快速發展的聚己內酯市場的關鍵市場洞察

供需的動態交互作用正在改變聚己內酯市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 消費者對生物分解性材料的認知不斷增強
    • 醫療保健領域快速成長，醫療產品需求不斷增加
  • 市場限制因素
    • 聚己內酯和聚己內酯基產品的高成本
  • 市場機會
    • 持續研發創新，推出新產品
    • 政府對生物相容性和生物分解性材料的支持
  • 市場挑戰
    • 具有成本效益的替代方案的可用性

波特的五力：駕馭聚己內酯市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解聚己內酯市場的外部影響

外部宏觀環境因素在塑造聚己內酯市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解聚己內酯市場的競爭狀況

對聚己內酯市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣聚己內酯市場供應商的績效評估

FPNV定位矩陣是評估聚己內酯市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了聚己內酯市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，聚己內酯市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 意識提升對生物分解性材料的認知
      • 醫療保健產業快速成長，醫療產品需求不斷增加
    • 抑制因素
      • 聚己內酯和聚己內酯基產品的高成本
    • 機會
      • 持續研發創新，推出新產品
      • 政府支持生物相容性和生物分解性材料的舉措
    • 任務
      • 具有成本效益的替代方案的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章聚己內酯市場：依形式

  • 顆粒
  • 顆粒

第7章聚己內酯市場：依製程分類

  • 羧酸的縮聚
  • 開迴路聚合

第8章聚己內酯市場：依應用分類

  • 生物醫學
    • 藥物輸送裝置
    • 手術植入
  • 塗層和TPU

第9章北美、南美洲聚己內酯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區聚己內酯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲聚己內酯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Asahi Kasei Chemicals Corporation
  • Ashland Inc.
  • BASF SE
  • Capa by Perstorp Group
  • CELLINK Bioprinting AB
  • Connect Chemicals GmbH
  • Corbion NV
  • Daicel Corporation
  • Durect Corporation
  • Huntsman Corporation
  • LANXESS AG
  • Merck KGaA
  • Nomisma Healthcare Pvt. Ltd.
  • Polylactide Material
  • Polysciences Inc.
  • Shandong INOV Polyurethane Co., Ltd.
Product Code: MRR-C002B1C99550

The Polycaprolactone Market was valued at USD 508.70 million in 2023, expected to reach USD 537.96 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 774.46 million by 2030.

Polycaprolactone (PCL) is a biodegradable polyester with a wide range of applications due to its properties like low melting point and high compatibility with various composite materials. Its scope significantly spans across sectors such as pharmaceuticals, automotive, healthcare, and packaging. In pharmaceuticals, PCL is critical for controlled drug release systems, while its application in healthcare extends to tissue engineering and implants owing to its biodegradability and biocompatibility. The automotive and packaging industries utilize PCL predominantly for its durability and flexibility. Market growth factors include increasing demand for biodegradable materials driven by environmental concerns and regulatory support favoring eco-friendly products. Technological advancements in production processes, further enhancing its mechanical properties and cost-effectiveness, also propel market expansion. A notable opportunity lies in the medical sector focusing on innovative tissue engineering solutions, fueled by rising investment in healthcare technologies. To capitalize on such opportunities, businesses can invest in research collaborations that focus on enhancing PCL's properties or developing composites with wider applicability. However, the market faces limitations such as competition from other biodegradable polymers and high costs associated with production and material processing. PCL's ability to address these challenges primarily depends on overcoming the cost barriers and improving production efficiencies. Companies can explore advancements in additive manufacturing technologies like 3D printing, which can utilize PCL for bespoke medical devices, or innovations in drug delivery systems that harness its controlled release metrics. The nature of the market is dynamic, with substantial R&D initiatives focusing on expanding the application scope of PCL. Businesses should prioritize sustainable practices and partnerships with research institutions to stay at the forefront of innovations, maximizing potentials in underexplored sectors such as advanced automotive components and eco-friendly packaging solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 508.70 million
Estimated Year [2024] USD 537.96 million
Forecast Year [2030] USD 774.46 million
CAGR (%) 6.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Polycaprolactone Market

The Polycaprolactone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing consumer awareness about biodegradable materials
    • Rapid growth of the healthcare sector and rising demand for medical products
  • Market Restraints
    • High costs of polycaprolactone and polycaprolactone-based products
  • Market Opportunities
    • Ongoing research and development for novel product innovations and launches
    • Supportive government initiatives for biocompatible and biodegradable materials
  • Market Challenges
    • Availability of cost-efficient substitute

Porter's Five Forces: A Strategic Tool for Navigating the Polycaprolactone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Polycaprolactone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Polycaprolactone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Polycaprolactone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Polycaprolactone Market

A detailed market share analysis in the Polycaprolactone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Polycaprolactone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Polycaprolactone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Polycaprolactone Market

A strategic analysis of the Polycaprolactone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Polycaprolactone Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Chemicals Corporation, Ashland Inc., BASF SE, Capa by Perstorp Group, CELLINK Bioprinting AB, Connect Chemicals GmbH, Corbion NV, Daicel Corporation, Durect Corporation, Huntsman Corporation, LANXESS AG, Merck KGaA, Nomisma Healthcare Pvt. Ltd., Polylactide Material, Polysciences Inc., and Shandong INOV Polyurethane Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Polycaprolactone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Granules and Pellets.
  • Based on Process, market is studied across Polycondensation of Carboxylic Acid and Ring Opening Polymerization.
  • Based on Application, market is studied across Biomedical and Coating & TPU. The Biomedical is further studied across Drug Delivery Devices and Surgical Implant.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumer awareness about biodegradable materials
      • 5.1.1.2. Rapid growth of the healthcare sector and rising demand for medical products
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of polycaprolactone and polycaprolactone-based products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for novel product innovations and launches
      • 5.1.3.2. Supportive government initiatives for biocompatible and biodegradable materials
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of cost-efficient substitute
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Polycaprolactone Market, by Form

  • 6.1. Introduction
  • 6.2. Granules
  • 6.3. Pellets

7. Polycaprolactone Market, by Process

  • 7.1. Introduction
  • 7.2. Polycondensation of Carboxylic Acid
  • 7.3. Ring Opening Polymerization

8. Polycaprolactone Market, by Application

  • 8.1. Introduction
  • 8.2. Biomedical
    • 8.2.1. Drug Delivery Devices
    • 8.2.2. Surgical Implant
  • 8.3. Coating & TPU

9. Americas Polycaprolactone Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Polycaprolactone Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Polycaprolactone Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Asahi Kasei Chemicals Corporation
  • 2. Ashland Inc.
  • 3. BASF SE
  • 4. Capa by Perstorp Group
  • 5. CELLINK Bioprinting AB
  • 6. Connect Chemicals GmbH
  • 7. Corbion NV
  • 8. Daicel Corporation
  • 9. Durect Corporation
  • 10. Huntsman Corporation
  • 11. LANXESS AG
  • 12. Merck KGaA
  • 13. Nomisma Healthcare Pvt. Ltd.
  • 14. Polylactide Material
  • 15. Polysciences Inc.
  • 16. Shandong INOV Polyurethane Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. POLYCAPROLACTONE MARKET RESEARCH PROCESS
  • FIGURE 2. POLYCAPROLACTONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POLYCAPROLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. POLYCAPROLACTONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. POLYCAPROLACTONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POLYCAPROLACTONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POLYCAPROLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POLYCAPROLACTONE MARKET DYNAMICS
  • TABLE 7. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY PELLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY POLYCONDENSATION OF CARBOXYLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY RING OPENING POLYMERIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY SURGICAL IMPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY COATING & TPU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 187. POLYCAPROLACTONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. POLYCAPROLACTONE MARKET, FPNV POSITIONING MATRIX, 2023